NeisVac-C group C meningococcal conjugate vaccine regulatory update

BAX's Hyland Immuno division received U.K. marketing approval for NeisVac-C to prevent meningococcal infection in children one year and older. NeisVac-C was developed by North American Vaccine Inc. (...